Russell Investments Group, Ltd. Terns Pharmaceuticals, Inc. Transaction History
Russell Investments Group, Ltd.
- $75.4 Billion
- Q2 2025
A detailed history of Russell Investments Group, Ltd. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 24,820 shares of TERN stock, worth $162,074. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,820
Previous 28,188
11.95%
Holding current value
$162,074
Previous $77,000
19.48%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TERN
# of Institutions
142Shares Held
84.3MCall Options Held
256KPut Options Held
133K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$53.3 Million1.87% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$49.4 Million0.65% of portfolio
-
Morgan Stanley New York, NY7.11MShares$46.4 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$45 Million5.17% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$36.4 Million0.54% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $246M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...